Account Info
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NRXP NRX Pharmaceuticals > Financial Statement > Income statement
NRXP NRX Pharmaceuticals
0.730
+0.030+4.29%
Post Mkt Price
0.740
+0.010+1.37%
Income statement Balance sheet Cash flow
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
0 0 0 0
Operating revenue
-- 0 -- 0 -- 0 -- 0
Cost of revenue
Gross profit
Operating expense
-54.52% 9.14M -43.92% 9.6M 270.49% 15.71M 693.46% 94.43M
Selling and administrative expenses
-63.74% 5.01M -46.68% 6.64M 386.53% 10.22M 555.33% 74.94M
-General and administrative expense
-63.74% 5.01M -46.68% 6.64M 386.53% 10.22M 555.33% 74.94M
Research and development costs
-34.21% 4.13M -36.51% 2.96M 88.48% 5.48M 90.65% 20.26M
Other operating expenses
-- -- -- -- -- -- 92.41% -771K
Operating profit
54.52% -9.14M 43.92% -9.6M -270.49% -15.71M -693.46% -94.43M
Net non-operating interest income expense
2,000.00% 95K 560.00% 23K 40.00% -3K 67.86% -18K
Non-operating interest income
-- 95K -- 23K -- -- -- --
Non-operating interest expense
-- 0 -- 0 -40.00% 3K -67.86% 18K
Other net income (expense)
99.78% -37K -84.74% 2.6M 110.64% 2.26M 103.48% 1.39M
Gain on sale of security
99.78% -37K -99.33% 116K -- 157K 6,366.67% 1.69M
Special income (charges)
-- 0 798.31% 2.48M 1,638.02% 2.1M 6,959.61% 21.06M
-Less：Restructuring and merger&acquisition
-- 0 -798.31% -2.48M -- -2.1M -- -20.94M
-Less:Other special charges
-- -- -- -- -- -- -139.41% -121K
Other non- operating income (expenses)
-- -- -- -- -- -- 45.89% -21.37M
Income before tax
75.48% -9.08M -5,816.95% -6.98M 47.24% -13.45M -79.74% -93.06M
Income tax
0
Net income
75.48% -9.08M -5,816.95% -6.98M 47.24% -13.45M -79.74% -93.06M
Net income continuous Operations
75.48% -9.08M -5,816.95% -6.98M 47.24% -13.45M -79.74% -93.06M
Minority interest income
Net income attributable to the parent company
75.48% -9.08M -5,816.95% -6.98M 47.24% -13.45M -79.74% -93.06M
Preferred stock dividends
Other preferred stock dividends
0 0 255.82M
Net income attributable to common stockholders
75.48% -9.08M 97.27% -6.98M 47.24% -13.45M -573.82% -348.89M
Basic earnings per share
79.29% -0.14 98.21% -0.11 70.42% -0.21 -392.72% -7.44
Diluted earnings per share
79.29% -0.14 98.29% -0.11 70.42% -0.21 -392.72% -7.44
Dividend per share
Currency Unit
USDUSDUSDUSD
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More
CEO： Mr. Stephen H. Willard
Market： NASDAQ
Listing Date： 12/01/2017
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist